Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 2, 1998, Pages 153-157

  Suppola, Juhana P ^a   Kuikka, Arja ^a   Vaara, Martti ^a,c   Valtonen, Ville V ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN;

ADULT; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BLOOD DISEASE; CATHETERIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; ENTEROCOCCUS FAECALIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEUTROPENIA; RETROSPECTIVE STUDY; RISK FACTOR; STRAIN DIFFERENCE; TREATMENT OUTCOME;

EID: 0031844766     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655498750003546     Document Type: Article

References (14)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 Suppl 3B: S72-5.
2. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995; 20: 296 301.
3. Boyle JF, Soumakis SA, Rendo A. Herrington A. Gianarkis DG, Thurberg BE, Painter BG. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 1280-5.
4. Shay DK, Maloney SA, Montecalvo M, Banerjee S. Wormser GD, Arduino MJ, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal blood stream infections. J Infect Dis 1995; 172: 993-1000.
5. Weinstein MP, Relier LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983; 5: 54-70.
6. Mackowiak PA. The enterococci: evidence of species-specific clinical and microbiological heterogeneity. Am J Med Sci 1989; 297: 238-43.
7. Weinstein MP, Relier LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiological observations. Rev Infect Dis 1983; 5: 35-53.
8. Malone DA, Wagner RA, Myers JP, Watanakunakorn C. Enterococcal bacteremia in two large community teaching hospitals. Am J Med 1986; 81: 601-6.
9. Von Reyn CF, Levy BS, Arbeit RD, Gerald F, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981; 94: 505-18.
10. McCarthy AE, Victor G, Ramotar K, Toye B. Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian Tertiary-Care hospital. J Clin Microbiol 1994; 32: 2671-6.
11. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infection by a conventional test scheme. J Clin Microbiol 1989; 27: 731-4.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS document M100-S5. National Committee for Clinical Laboratory Standards, Villanova PA., 1994.
13. Suppola JP, Volin L, Valtonen VV. Vaara M. Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infec Dis 1996; 23: 694 7.
14. Coque TM, Patterson JH, Steckelherg JM, Murray BE. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J Infect Dis 1995; 171: 1223-9.